Nuclear medicine, a type ofimagingthat uses radioactive materials, is a useful tool to detect and also treatprostate cancer. It is a form ofdiagnostic imagingthat helps radiologists determine the stage ofcancer.
This report contains market size and forecasts of Prostate Cancer Nuclear Medicine Diagnostics in Global, including the following market information:
- Global Prostate Cancer Nuclear Medicine Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Prostate Cancer Nuclear Medicine Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
SPECT Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Nuclear Medicine Diagnostics include Blue Earth Diagnostics, PETNET Solutions, Cardinal Health, Lantheus Medical Imaging, Jubilant Pharma, NCM-USA, Progenics Pharma, Telix Pharma and ImaginAb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Nuclear Medicine Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Nuclear Medicine Diagnostics Market Segment Percentages, by Type, 2021 (%)
Global Prostate Cancer Nuclear Medicine Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Nuclear Medicine Diagnostics Market Segment Percentages, by Application, 2021 (%)
Global Prostate Cancer Nuclear Medicine Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prostate Cancer Nuclear Medicine Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Prostate Cancer Nuclear Medicine Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Prostate Cancer Nuclear Medicine Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Blue Earth Diagnostics
- PETNET Solutions
- Cardinal Health
- Lantheus Medical Imaging
- Jubilant Pharma
- NCM-USA
- Progenics Pharma
- Telix Pharma
- ImaginAb
- Theragnostics
- Novartis
- Alliance Medical
